These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6235872)

  • 21. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1981 Jan; 72(1):81-8. PubMed ID: 7225714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans.
    Visser A; Meuleman DG
    Thromb Res; 1990 Jun; 58(5):469-79. PubMed ID: 2164263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
    Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
    J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.
    Chang X; Yamada R; Yamamoto K
    Arthritis Res Ther; 2005; 7(2):R268-73. PubMed ID: 15743473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
    Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
    Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
    Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
    Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
    J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis.
    Delorme MA; Saeed N; Sevcik A; Mitchell L; Berry L; Johnston M; Andrew M
    Blood; 1993 Dec; 82(11):3380-5. PubMed ID: 8241508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.
    Cosmi B; Fredenburgh JC; Rischke J; Hirsh J; Young E; Weitz JI
    Circulation; 1997 Jan; 95(1):118-24. PubMed ID: 8994426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
    Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S
    Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB; Edward M; Winter JH; Bennett NB
    Thromb Res; 1980 Feb 1-15; 17(3-4):539-44. PubMed ID: 6768163
    [No Abstract]   [Full Text] [Related]  

  • 36. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
    McGuire EA; Tollefsen DM
    J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
    Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
    Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin.
    Luzzatto G; Paolini R; Stevanato F; Simioni P; Cella G
    Angiology; 1989 Mar; 40(3):170-4. PubMed ID: 2916768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-affinity material does not contribute to the antithrombotic activity of Orgaran (Org 10172) in human plasma.
    Zammit A; Dawes J
    Thromb Haemost; 1994 Jun; 71(6):759-67. PubMed ID: 7526481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.